Cidara Therapeutics shares are trading lower by 24.4% Monday afternoon. The company announced a 1-for-20 reverse stock split. Memorial Day Special: Access your full investing command center with trade ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Cidara Therapeutics Inc (Symbol: CDTX), where a total of 6,238 contracts have traded so far ...

The average one-year price target for Cidara Therapeutics (NasdaqCM:CDTX) has been revised to $185.77 / share. This is an increase of 10.71% from the prior estimate of $167.79 dated November 7, 2025.

Cidara Therapeutics, Inc. (NASDAQ:CDTX) is one of the Hot Growth Stocks to Invest in Now. On October 16, Maxwell Skor from Morgan Stanley initiated coverage of Cidara Therapeutics, Inc. (NASDAQ:CDTX) ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Cidara Therapeutics, Inc. (NASDAQ:CDTX) stock is trading over 90% higher on Monday with a session volume of 3.2 million compared to the average volume of 181.7K. On Monday, the company released ...

Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 5.39% (Institutional ...

Investors might want to bet on Cidara Therapeutics (CDTX), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Cidara Therapeutics CDTX announced that the FDA has granted a Breakthrough Therapy designation to its lead pipeline candidate, CD388, for the prevention of seasonal influenza. Shares of the company ...